Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb Trial
Genovese MC et al. J Rheumatol 2018; Advance online publication. doi: 10.3899/jrheum.170344
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.